The 25th China Biological Products Annual Conference (CBioPC2026) --- Parallel Session on Vaccine R&D Strategies and Internationalization

Date: May 16, 2026

Venue: Room 302, Nanjing International Expo Conference Center

Agenda:

8:30–8:35  Moderator’s opening remarks and introduction of speakers

Moderator: Li Meng, Director of International Business Department, China National Biotec Group Co., Ltd.

8:35–9:05  Policy, Innovation, and Emergency Preparedness: A Study on the Development of China’s Vaccine Industry

Speaker: Tang Wenxi, Professor, China Pharmaceutical University

9:05–9:35  R&D Strategy Planning for Vaccine Products Targeting International Markets

Speaker: Yuan Yuan, China Country Representative, PATH

9:35–10:05  Case Sharing on Vaccine R&D Strategies and Global Layout

Speaker: Tong Xin, Executive Deputy Director, Yunnan Vaccine Laboratory

10:05–10:20  Tea Break

10:20–10:50  Challenges and Strategies for Vaccine Companies Going Global

Speaker: Zhang Qian, Director of International Business, Beijing Sinovac Biotech (Group) Co., Ltd.

10:50–11:35  Roundtable Discussion: Breaking Through to Global Markets, Where Should We Set Our Sights? - The RSV Vaccine Example

Moderator: Yanan Luyao, Head of Technology Transfer, Beijing Minhai Biotechnology Co., Ltd.

Panelists:

Wang Bin, Professor, Fudan University

Chen Dexiang, Chairman and General Manager, Chengdu Maxvax Biotechnology Co., Ltd. 

Wang Tianping, Director of International Registration, Beijing Sinovac Biotech (Group) Co., Ltd.

Feng Yang, General Manager, Xiamen Chazen Biomedical Technology Co., Ltd.

11:35–11:45  Summary

Moderator: Li Meng, Director of International Business Department, China National Biotec Group Co., Ltd.

Link: https://mp.weixin.qq.com/s/i2WVPYcdV6DS2E7GxReymA